Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging

被引:133
作者
Thambisetty, Madhav [1 ]
Metter, Jeffrey [1 ]
Yang, An [1 ]
Dolan, Hillary [2 ]
Marano, Christopher [3 ]
Zonderman, Alan B. [1 ]
Troncoso, Juan C. [4 ]
Zhou, Yun [5 ]
Wong, Dean F. [5 ]
Ferrucci, Luigi [1 ]
Egan, Josephine [1 ]
Resnick, Susan M. [1 ]
O'Brien, Richard J. [2 ]
机构
[1] NIA, Res Program, Baltimore, MD 21224 USA
[2] Johns Hopkins Bayview Med Ctr, Dept Neurol, Baltimore, MD 21224 USA
[3] Johns Hopkins Bayview Med Ctr, Dept Psychiat, Baltimore, MD 21224 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
COGNITIVE DECLINE; DIABETES-MELLITUS; TOLERANCE TEST; RISK; DEMENTIA; COMMUNITY; BRAIN; IMPAIRMENT; ROTTERDAM; HISAYAMA;
D O I
10.1001/jamaneurol.2013.284
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IMPORTANCE Peripheral glucose homeostasis has been implicated in the pathogenesis of Alzheimer disease (AD). The relationship among diabetes mellitus, insulin, and AD is an important area of investigation. However, whether cognitive impairment seen in those with diabetes is mediated by excess pathological features of AD or other related abnormalities, such as vascular disease, remains unclear. OBJECTIVE To investigate the association between serial measures of glucose intolerance and insulin resistance and in vivo brain beta-amyloid burden, measured with carbon 11-labeled Pittsburgh Compound B (11C-PiB), and AD pathology at autopsy. DESIGN Scores calculated from the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) and Braak criteria were correlated with measures of hyperglycemia, hyperinsulinemia, glucose intolerance, and insulin resistance in 197 participants who underwent autopsy after death and who had undergone 2 or more oral glucose tolerance tests (OGTT) using grouped analyses and a continuous mixed-models analysis. The same measures of glucose intolerance and insulin resistance were also correlated with brain 11C-PiB retention in an additional 53 living subjects from the Baltimore Longitudinal Study of Aging neuroimaging study. SETTING Prospective, serially assessed cohort of community-dwelling subjects. PARTICIPANTS Cohort 1 consisted of 197 participants enrolled in the Baltimore Longitudinal Study of Aging who had 2 or more OGTTs during life and a complete brain autopsy after death. Cohort 2 consisted of 53 living subjects who had 2 or more OGTTs and underwent brain 11C-PiB positron emission tomography. EXPOSURES Autopsy and 11C-PiB positron emission tomography. MAIN OUTCOMES AND MEASURES The correlation of brain markers of AD, including CERAD score, Braak score, and 11C-PiB retention, with serum markers of glucose homeostasis using grouped and continuous mixed-models analyses. RESULTS We found no significant correlations between measures of brain AD pathology or 11C-PiB beta-amyloid load and glucose intolerance or insulin resistance in subjects who had a mean (SD) of 6.4 (3.2) OGTTs during 22.1 (8.0) years of follow-up. Thirty subjects with frank diabetes mellitus who received medications also had AD pathology scores that were similar to those of the cohort as a whole. CONCLUSIONS AND RELEVANCE In this prospective cohort with multiple assessments of glucose intolerance and insulin resistance, measures of glucose and insulin homeostasis are not associated with AD pathology and likely play little role in AD pathogenesis. Long-term therapeutic trials are important to elucidate this issue.
引用
收藏
页码:1167 / 1172
页数:6
相关论文
共 35 条
[1]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[2]   Diabetes is related to cerebral infarction but not to AD pathology in older persons [J].
Arvanitakis, Z. ;
Schneider, J. A. ;
Wilson, R. S. ;
Li, Y. ;
Arnold, S. E. ;
Wang, Z. ;
Bennett, D. A. .
NEUROLOGY, 2006, 67 (11) :1960-1965
[3]   Diabetes and Cognitive Systems in Older Black and White Persons [J].
Arvanitakis, Zoe ;
Bennett, David A. ;
Wilson, Robert S. ;
Barnes, Lisa L. .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2010, 24 (01) :37-42
[4]   Prevalence of diabetes and effect on quality of life in older French living in the community: The PAQUID epidemiological survey [J].
BourdelMarchasson, I ;
Dubroca, B ;
Manciet, G ;
Decamps, A ;
Emeriau, JP ;
Dartigues, JF .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (03) :295-301
[5]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[6]   Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study [J].
Bruce, DG ;
Casey, GP ;
Grange, V ;
Clarnette, RC ;
Almeida, OP ;
Foster, JK ;
Ives, FJ ;
Davis, TME .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) :59-67
[7]   Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging [J].
Burns, Jeffrey M. ;
Honea, Robyn A. ;
Vidoni, Eric D. ;
Hutfles, Lewis J. ;
Brooks, William M. ;
Swerdlow, Russell H. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03) :333-339
[8]   Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly [J].
Convit, A ;
Wolf, OT ;
Tarshish, C ;
de Leon, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2019-2022
[9]   Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial [J].
Craft, Suzanne ;
Baker, Laura D. ;
Montine, Thomas J. ;
Minoshima, Satoshi ;
Watson, G. Stennis ;
Claxton, Amy ;
Arbuckle, Matthew ;
Callaghan, Maureen ;
Tsai, Elaine ;
Plymate, Stephen R. ;
Green, Pattie S. ;
Leverenz, James ;
Cross, Donna ;
Gerton, Brooke .
ARCHIVES OF NEUROLOGY, 2012, 69 (01) :29-38
[10]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, P214